Efficacy of Collagenase Clostridium Histolyticum for Dupuytren Disease: A Systematic Review

Efficacy of Collagenase Clostridium Histolyticum for Dupuytren Disease: A Systematic Review

Abstract Introduction Collagenase Clostridium Histolyticum (CCH) has become a therapeutic alternative for Dupuytren disease. However, its efficacy in the medium to long term is unknown. The objective of our study is to carry out a systematic review of the studies conducted on the subjec...

Full description

Bibliographic Details
Main Authors:	Rafael Sanjuan-Cerveró, Pedro Vazquez-Ferreiro, Diego Gomez-Herrero, Francisco Javier Carrera-Hueso
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações Ltda. 2017-11-01
Series:	Revista Iberoamericana de Cirugía de la Mano
Subjects:	collagenase clostridium histolyticum efficacy systematic review
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1608749

Similar Items

Collagenase clostridium histolyticum for the treatment of Dupuytren’s contracture: systematic review and economic evaluation
by: Miriam Brazzelli, et al.
Published: (2015-10-01)

Lateral herniation during treatment with collagenase Clostridium histolyticum (Xiaflex) for Peyronie’s disease
by: Margaret K. Gannon, et al.
Published: (2021-06-01)

The efficacy and safety of intralesional injection of collagenase Clostridium histolyticum for Peyronie’s disease: A meta-analysis of published prospective studies
by: Fuxun Zhang, et al.
Published: (2022-10-01)

Safety and Efficacy Study of Collagenase Clostridium Histolyticum Applied With an Intensive Protocol in the Treatment of Peyronie's Disease
by: Mª Teresa Melgarejo-Segura, et al.
Published: (2021-06-01)

Collagenase Clostridium histolyticum in the treatment of Peyronie’s disease: patient selection and perspectives
by: Kuhlmann PK, et al.
Published: (2017-03-01)

Multiple concurrent collagenase clostridium histolyticum injections to dupuytren’s cords: an exploratory study
by: Coleman Stephen, et al.
Published: (2012-04-01)

Short-term efficacy and adverse effects of collagenase clostridium histolyticum injections, percutaneous needle fasciotomy and limited fasciectomy in the treatment of Dupuytren’s contracture: a network meta-analysis of randomized controlled trials
by: Doha Obed, et al.
Published: (2022-10-01)

Improvement in the ability to have sex in patients with Peyronie's disease treated with Collagenase Clostridium histolyticum
by: Jeannette P. Geelhoed, et al.
Published: (2023-01-01)

Treatment Patterns and Healthcare Outcomes with Collagenase Clostridium Histolyticum vs Surgery in Peyronie's Disease: A Retrospective Claims Database Analysis
by: Landon Trost, MD, et al.
Published: (2021-04-01)

Optimization of Col H Gene Encoding Clostridium histolyticum Collagenase to Express in Escherichia coli
by: Seyed Mohammad Amin Mahdian, et al.
Published: (2022-01-01)

The Impact of Clostridium Histolyticum Collagenase on the Prevalence and Management of Peyronie’s Disease in the United States
by: Andrew J. Sun, et al.
Published: (2019-05-01)

Expanded Utilization of Intralesional Therapies for Treatment of Peyronie’s Disease
by: Khooblall P, et al.
Published: (2023-06-01)

Vascular Necrosis of the Upper Extremity After Self-Treatment for Peyronie's Disease
by: David Yang, MD, et al.
Published: (2021-02-01)

Treatment of Dupuytren’s contracture with collagenase clostridium histolyticum under clinical practice conditions: ReDUCTo study
by: Haerle, Max, et al.
Published: (2015-08-01)

Monitoring the Degradation of Collagen Hydrogels by Collagenase <i>Clostridium histolyticum</i>
by: Hon Wei Ng, et al.
Published: (2020-11-01)

Efectividad del tratamiento de la enfermedad de Dupuytren (ED) mediante fasciotomía enzimática con colagenasa. Estudio multicéntrico cohortes prospectivo
by: A. García Olea, et al.
Published: (2014-11-01)

Changes in the Effects of Peyronie's Disease After Treatment With Collagenase Clostridium histolyticum: Male Patients and Their Female Partners
by: Irwin Goldstein, MD, et al.
Published: (2017-06-01)

Collagenase Clostridium Histolyticum in the Treatment of Peyronie’s Disease: Review of a Minimally Invasive Treatment Option
by: Andrew T Gabrielson, et al.
Published: (2017-12-01)

Discovery of New Microbial Collagenase Inhibitors
by: Georgiana Nitulescu, et al.
Published: (2022-12-01)

Current Trends in the Treatment of Dupuytren Disease in Spain
by: Rafael Sanjuan-Cerveró, et al.
Published: (2020-05-01)

How Atypical Penile Curvature Influence Clinical Outcomes in Patients with Peyronie’s Disease Receiving Collagenase Clostridium Histolyticum Therapy?
by: Andrea Cocci, et al.
Published: (2020-01-01)

Late complications of clinical clostridium histolyticum collagenase use in Dupuytren's disease.
by: Warren M Rozen, et al.
Published: (2012-01-01)

[Translated article] Colagenasa Clostridium histolyticum for Dupuytren's disease: A shooting star
by: R. Sanjuan-Cerveró
Published: (2022-05-01)

Presentation, Management, and Outcomes of Penile Fractures
by: Meher Pandher, et al.
Published: (2022-11-01)

Clostridium histolyticum (AA4500) for the Treatment of Adhesive Capsulitis of the Shoulder: A Randomised Double-Blind, Placebo-Controlled Study for the Safety and Efficacy of Collagenase – Single Site Report
by: Fitzpatrick J, et al.
Published: (2020-07-01)

Colagenasa Clostridium histolyticum para la enfermedad de Dupuytren: una estrella fugaz
by: R. Sanjuan-Cerveró
Published: (2022-05-01)

Retraction: Late complications of clinical Clostridium histolyticum collagenase use in Dupuytren's disease.
Published: (2012-01-01)

Delayed vascular complication after collagenase injection for Dupuytren disease
by: Jesper Nordenskjöld, et al.
Published: (2023-10-01)

Acute Pain Intensity After Collagenase Clostridium histolyticum Injection in Patients With Dupuytren Contracture
by: Kimitoshi Noto, MD, et al.
Published: (2020-01-01)

The efficacies and limitations of fasciectomy and collagenase clostridium histolyticum in Dupuytren’s contracture management: A meta-analysis
by: Tokai B Cooper, et al.
Published: (2020-06-01)

Risk Factors for Long-Term Contracture Recurrence after Collagenase Injection for Dupuytren Disease: A Prospective Cohort Study
by: David Eckerdal, et al.
Published: (2023-02-01)

Clostridium Histolyticum Collagenase Underdosed for Multicord Injection in Dupuytren’s Disease: A Retrospective Cohort Study
by: Filippo Boriani, MD, MSc, PhD, et al.
Published: (2022-11-01)

Magnetic resonance imaging of diffusion characteristics following collagenase clostridium histolyticum injection in Dupuytren’s contracture
by: Hiroko Iwakawa, et al.
Published: (2021-09-01)

Intralesional collagenase Clostridium histolyticum vs. verapamil injections in males with Peyronie’s Disease: A prospective, matched-pair, non-blinded, randomised clinical study comparing clinical outcomes and patient satisfaction rates
by: Eric Chung, et al.
Published: (2022-09-01)

CLINICAL RESULTS OF COLLAGENASE TREATMENT FOR DUPUYTREN’S DISEASE: A CASE SERIES STUDY WITH 2-YEARS FOLLOW-UP
by: Morena Anna Basso, et al.
Published: (2023-04-01)

Clostridium Collagenase Impact on Zone of Stasis Stabilization and Transition to Healthy Tissue in Burns
by: Rosanne E. Frederick, et al.
Published: (2021-08-01)

Localized co-delivery of collagenase and trastuzumab by thermosensitive hydrogels for enhanced antitumor efficacy in human breast xenograft
by: Anni Pan, et al.
Published: (2018-01-01)

Endogenous Collagenases Regulate Osteoclast Fusion
by: Hyo Jeong Kim, et al.
Published: (2020-05-01)

Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis
by: Zah V, et al.
Published: (2020-11-01)

The role of collagenase in emphysema
by: D'Armiento Jeanine, et al.
Published: (2001-09-01)